Is ASP Isotopes Inc. Common Stock (ASPI) a Buy, Sell, or Hold?
NASDAQ : ASPI
ASP Isotopes Inc. Common Stock
$4.43 USD
$0.33 (8.05%)
- Volume
- 3.38M
- Average Volume
- 4.88M
- Market Capitalization
- $557.75M
- P/E Ratio
- -2.13
- Dividend Yield
- 0.00%
- Price Target
- $9.25
- Year High
- $14.49
- Year Low
- $3.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.39
Company Overview
NASDAQ
Paul Elliot Mann
Chemicals
Basic Materials
ASPI
271
US
USD
Liquidity Metrics
0.91
4.39
4.37
2.95
0.00
Sales & Valuation
$23.85M
20.71
1.85
-8.48
-0.54
Profitability
-$2.11
-$175.09M
-644.41%
-660.17%
-117.16%
-29.53%
P/E Metrics
-2.13
0.02
0.02
Analyst Price Target & Rating
$9.25
$15.00
$4.50
1/5
2 Analysts
-52.11%
Financial Health Scores
-0.31
3/9
$238.37M
$587.67M
$288.65M
-$175.43M
Key Metrics (TTM)
$612.24M
22.74
-3.59
4.39
-117.16%
-12.97%
-32.37%
-11.80%
-28 days
Company Executives
| Name | Title |
|---|---|
| Paul Elliot Mann | Executive Chairman & CEO |
| Stefano Marani | President of Electronics & Space |
| Donald George Ainscow | EVP, General Counsel & Secretary |
| Heather Kiessling | Chief Financial Officer |
| Nicholas Michael Mitchell | Co-Chief Operating Officer |
| Robert Ainscow | Chief Operating Officer |
| Gerdus Kemp | Medical Director & Chief Executive Officer of Pet Labs |
| Hendrik T. van Wyk | Head of Engineering |
| Hendrik Strydom | Chief Technology Officer |
| Xandra van Heerden | Head of Research & Development |
Poll Results
No votes yet today — be the first to share your view!
About ASP Isotopes Inc. Common Stock (NASDAQ:ASPI) Stock
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida. ...
2026-08-06 08:00:00
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into an additional take-or-pay contract to supply liquified natural gas (LNG) to a domestic food processor, establishing a multi-year contracted cash flow supporting Phase 1 commercial operations, which remain targeted for completion in the third quarter of 2026
ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference
2026-08-05 08:00:00
DALLAS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will host investor meetings at Citi's 2026 Natural Resources Conference on Thursday, August 13, 2026, in Las Vegas, Nevada.
Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress
2026-08-04 08:01:50
Washington D.C., August 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aeternum Health (OTC: AETN) (“Company”), today announced a change in strategy, new management and provides investors with an update on corporate progress.
ASP Isotopes Issues Letter to Shareholders
2026-08-04 08:00:00
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today released the following letter to shareholders from its Executive Chairman and Chief Executive Officer, Paul Mann. Dear Fellow Shareholder, As we prepare to announce financial results for the second quarter of 2026, I wanted to take this opportunity to update you on the developments taking place at ASP Isotopes Inc. All of our business units are making considerable progress, group revenues are increasing, and three of our business units appear at an inflection point and are expected to make substantial contributions to achieving profitability in the near term: During 1H 2026, our global PET Labs group demonstrated organic revenue growth of over 50% as compared to 1H 2025.
ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
2026-07-30 08:00:00
DALLAS, July 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Viktor Petkov, Chief Commercial Officer, will deliver a company presentation on Wednesday, August 12, 2026, at 8:00 a.m. ET. A live audio webcast of the presentation will be available in the Investors section of the Company's website at www.aspisotopes.com.
ASP Isotopes to Hold Capital Markets Day on September 8
2026-07-28 08:00:00
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, beginning at 10:00 a.m. ET (3:00 p.m. BST).
2026-07-21 22:53:55
ASP Isotopes Inc. (ASPI) Discusses Noble Africa's Merger Plans and Strategy to Become a Publicly Traded Helium Platform Transcript
ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Production
2026-07-21 18:05:14
ASP Isotopes NASDAQ: ASPI executives outlined plans to create a publicly listed helium and liquefied natural gas platform through Noble Africa, emphasizing Renergen's South African helium resource, expected near-term production milestones and the proposed merger with ENDRA Life Sciences.
Frequently Asked Questions
-
What is the current ASP Isotopes Inc. Common Stock (ASPI) stock price?
-
ASP Isotopes Inc. Common Stock(NASDAQ:ASPI) stock price is $4.43 in the last trading session. During the trading session, ASPI stock reached the peak price of $14.49 while $3.51 was the lowest point it dropped to. The percentage change in ASPI stock occurred in the recent session was 8.05% while the dollar amount for the price change in ASPI stock was $0.33.
-
ASPI's industry and sector of operation?
-
The NASDAQ listed ASPI is part of Chemicals industry that operates in the broader Basic Materials sector.
-
Who are the executives of ASPI?
-
Paul Elliot Mann | Executive Chairman & CEO
Stefano Marani | President of Electronics & Space
Donald George Ainscow | EVP, General Counsel & Secretary
Heather Kiessling | Chief Financial Officer
Nicholas Michael Mitchell | Co-Chief Operating Officer -
How many employees does ASPI have?
-
Number of ASPI employees currently stands at 271. ASPI operates from 2200 Ross Avenue, Dallas, TX 75201, US.
-
Link for ASPI official website?
-
Official Website of ASPI is: aspisotopes.com
-
How do I contact ASPI?
-
ASPI could be contacted at phone #561 709 3034 and can also be accessed through its website. ASPI operates from 2200 Ross Avenue, Dallas, TX 75201, US.
-
How many shares of ASPI are traded daily?
-
The average number of ASPI shares traded daily for last 3 months was 4.88M.
-
What is the market cap of ASPI currently?
-
The market value of ASPI currently stands at $557.75M with its latest stock price at $4.43